skip to navigation skip to content
Search

biotech

Biotech vs big pharma

Most approved "priority" medicines are developed by biotech rather than large pharmaceutical firms, says a two-decade study at the University of Cambridge Judge Business School. Biotech companies created 40 per cent more US Food & Drug Administration-approved "priority" drugs than…

Read more

2020 brainfood oraiopoulos derisking drug innovation 1998x642 1

Growth recognition

Cambridge Healthcare Research, co-founded by Cambridge MBA alumnus Max Rubin (MBA 2010), awarded Queen's Award for Enterprise. Cambridge Healthcare Research Ltd, a firm whose Founding Partner is Cambridge MBA graduate Max Rubin (MBA 2010), was awarded a Queen's Award for…

Read more

2020 news growth recognition 883x432 2

Cambridge Judge supported biotech firm joins the global coronavirus fight

Healx, a biotech firm that was supported by the Entrepreneurship Centre at Cambridge Judge Business School, says it is using its artificial intelligence (AI) platform to develop drug combinations from approved drugs to seek treatments for COVID-19. The Cambridge-based company,…

Read more

2020 news healx 883x432 1

Best first-day IPO

Cancer therapy company Monopar Therapeutics, led by Cambridge MBA Chandler Robinson, has very successful initial public offering (IPO) on Nasdaq. Monopar, a Chicago-based company seeking to improve clinical outcomes for cancer patients, led by Cambridge Judge Business School graduate Chandler…

Read more

2020 news best first day ipo 883x432 1

Venturing forth: ET-traps

A biotech entrepreneurial weekend at Cambridge Judge Business School kickstarted a venture that seeks to tackle diabetes through a novel treatment. Dr Arjun Jain was pursuing his PhD in Reproductive Biochemistry at the University of Cambridge back in 2008. It…

Read more

2020 venturing forth et traps 883x432 1 1

Business Weekly: New £25m China investment for Cambridge life sciences lined up via Cambridge Judge and AZ

China Medical System, a pharmaceutical company listed on the Hong Kong Stock Exchange, has signalled its confidence in the UK biotech and life sciences sectors through intended investment of up to £25 million in early stage UK biotech and life…

Read more

China Medical System (CMS) to invest up to £25 million to support early stage biotech firms in the UK with a Cambridge focus

CMS, a speciality pharmaceutical company listed on the Hong Kong Stock Exchange, has signalled its confidence in the UK biotech and life sciences sectors through intended investment in early stage UK biotech and life sciences businesses, with support from AstraZeneca…

Read more

2019 news china medical systems investment 883x432 1

Movers and shakers

Five women associated with Cambridge Judge Business School are named in BioBeat report on 50 top women leaders and innovators in biotech. Five women associated with Cambridge Judge Business School are included in the sixth annual 50 Movers and Shakers…

Read more

2019 news moversandshakers 883x432 1

Business Weekly: AstraZeneca and Cambridge Judge Business School seek new life science gazelles

Cambridge Judge Business School partnered with Astra Zeneca for an initiative aiming to “highlight the great science and innovation taking place in the Cambridge ecosystem and help build the next generation of biotechs.” Three finalists will be invited to pitch…

Read more

Working in pharma: the value of an EMBA

Three pharmaceutical professionals discuss how the Cambridge EMBA has helped their careers in the sector. The Cambridge Executive MBA programme attracts talented senior professionals from a variety of professions and industries. For EMBA participants working in the pharmaceutical sector, their…

Read more

2018 embanews workinginpharma

Archives